Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to SchwannomatosisUnknown
NCT04163419Phase 2Updated Mar 13, 2024
Sponsor: Massachusetts General Hospital
Schwannomatosis · Pain
United States
A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid TumorsCompleted
NCT01543698Phase 1, Phase 2Updated Mar 13, 2024
Sponsor: Pfizer
Solid Tumors Harboring a BRAF V600 Mutation
United States, Australia, Belgium, Canada, France +4 more
Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.Unknown
NCT02260466NAUpdated Mar 13, 2024
Sponsor: French Cardiology Society
Heart Disease · Aging · Amyloidosis · Aortic Valve Stenosis
France
A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese AdultsCompleted
NCT04916795Phase 1Updated Mar 12, 2024
Sponsor: Pfizer
Healthy
China
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against InfluenzaCompleted
NCT05052697Phase 1, Phase 2Updated Mar 12, 2024
Sponsor: Pfizer
Influenza, Human
United States
The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy PatientsCompleted
NCT04828993Phase 4Updated Mar 12, 2024
Sponsor: Pfizer
Transthyretin Amyloid Polyneuropathy (ATTR-PN)
China
Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South KoreaCompleted
NCT02156895N/AUpdated Mar 8, 2024
Sponsor: Pfizer
Advanced Renal Cell Carcinoma
South Korea
A Study Of PF-04449913 Administered Alone In Select Solid TumorsCompleted
NCT01286467Phase 1Updated Mar 6, 2024
Sponsor: Pfizer
Solid Tumors
United States
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID DiagnosticsRecruiting
NCT05979545Phase 4Updated Mar 6, 2024
Sponsor: National University of Singapore
Blood Stream Infections · Ventilator Associated Pneumonia · Healthcare Associated Infection · Carbapenem-Resistant Enterobacteriaceae Infection
Malaysia, Taiwan, Thailand
Retrospective Real World Oxbryta® Data Collection and Analysis StudyCompleted
NCT04930328N/AUpdated Mar 6, 2024
Sponsor: Pfizer
Sickle Cell Disease
United States
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerTerminated
NCT03709082Phase 1, Phase 2Updated Mar 5, 2024
Sponsor: University of Kansas Medical Center
HER2-positive Breast Cancer · Breast Cancer Metastatic
United States
LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF MelanomaCompleted
NCT02159066Phase 2Updated Mar 5, 2024
Sponsor: Pfizer
Melanoma
United States, Australia, Canada, Germany, Italy +4 more
Top-down Infliximab Study in Kids With Crohn's DiseaseCompleted
NCT02517684Phase 4Updated Mar 5, 2024
Sponsor: Erasmus Medical Center
Crohn's Disease
Belgium, Finland, Netherlands
A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in DenmarkCompleted
NCT05452798N/AUpdated Mar 1, 2024
Sponsor: Pfizer
Breast Cancer
Denmark
PF-04634817 Renal Impairment StudyCompleted
NCT01791855Phase 1Updated Mar 1, 2024
Sponsor: Pfizer
Renal Insufficiency
United States
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.Withdrawn
NCT06163677N/AUpdated Mar 1, 2024
Sponsor: Pfizer
COVID-19 · Coronavirus Disease 2019 · Influenza
A Study of MD-120 in Patients With DepressionCompleted
NCT04345471Phase 3Updated Feb 29, 2024
Sponsor: Mochida Pharmaceutical Company, Ltd.
Major Depressive Disorder
Japan
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1Completed
NCT02034981Phase 2Updated Feb 28, 2024
Sponsor: UNICANCER
Hematologic Cancers · Solid Tumors · Metastatic Cancer
France
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and OncologyCompleted
NCT02140736N/AUpdated Feb 28, 2024
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Chemotherapy-induced Symptomatic Anemia · Solid Tumors · Malignant Hemopathies · Lymphomas
France
A Relative Bioavailability Study Evaluating Two New Encorafenib FormulationsCompleted
NCT05446142Phase 1Updated Feb 23, 2024
Sponsor: Pfizer
Healthy
United States
Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.Completed
NCT04748445N/AUpdated Feb 23, 2024
Sponsor: Pfizer
Healthy
United States
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompleted
NCT04230213Phase 3Updated Feb 22, 2024
Sponsor: Pfizer
Rheumatoid Arthritis
United States, Bosnia and Herzegovina, Bulgaria, Czechia, Lithuania +5 more
A Study of Single Ascending Doses of PF-07258669 in Healthy Adult ParticipantsCompleted
NCT04628793Phase 1Updated Feb 21, 2024
Sponsor: Pfizer
Healthy Participants
United States
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By GenotonormCompleted
NCT00163189Phase 3Updated Feb 21, 2024
Sponsor: Pfizer
Growth Hormone Deficiency
France
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian CancerCompleted
NCT03936270Phase 2Updated Feb 20, 2024
Sponsor: Latin American Cooperative Oncology Group
Ovarian Cancer
Brazil

Previous page Next page